Studies find Omicron related hospitalisations lower in severity than Delta and Pfizer-BioNTech COVID vaccine remains effective in preventing hospitalisations

Adult hospitalisations from Omicron-related SARS-CoV-2 (COVID-19) were less severe than Delta and the Pfizer-BioNTech vaccine remains effective in preventing no

Related Keywords

China ,Bristol ,City Of ,United Kingdom ,Adam Finn ,Rob Challen ,Catherine Hyams ,Anastasia Chatzilena ,Elizabeth Blackwell Institute ,Twitter ,Doctoral Clinical Research ,University Hospitals Bristol ,Postdoctoral Research ,Foundation Trust ,Pfizer ,Department Of Engineering Mathematics ,Pfizer Inc ,Emergency Research Group ,Lancet Regional Health ,University Of Bristol ,Post Doctoral Clinical Research Fellow ,Principal Investigator ,Leon Danon ,Associate Professor ,Infectious Disease Modelling ,Data Analytics ,Engineering Mathematics ,North Bristol ,Postdoctoral Research Associate ,Professor Adam Finn ,Research Group ,Blackwell Institute ,Newswise ,Ovid 19 Omicron Delta Pfizer Biontech Covid Vaccine Hospitalisations Respiratory Infection Comirnaty Bnt162b2 By ,All Journal News ,Healthcare ,Infectious Diseases ,Public Health ,Vaccines ,Coronavirus ,